Immunity to SARS-CoV-2 up to 15 months after infection.

Marcotte H, Piralla A, Zuo F, Du L, Cassaniti I, Wan H, Kumagai-Braesh M, Andréll J, Percivalle E, Sammartino JC, Wang Y, Vlachiotis S, Attevall J, Bergami F, Ferrari A, Colaneri M, Vecchia M, Sambo M, Zuccaro V, Asperges E, Bruno R, Oggionni T, Meloni F, Abolhassani H, Bertoglio F, Schubert M, Calzolai L, Varani L, Hust M, Xue Y, Hammarström L, Baldanti F, Pan-Hammarström Q

iScience - (-) 103743 [2022-01-07; online 2022-01-07]

Information concerning the longevity of immunity to SARS-CoV-2 following natural infection may have considerable implications for durability of immunity induced by vaccines. Here, we monitored the SARS-CoV-2 specific immune response in COVID-19 patients followed up to 15 months after symptoms onset. Following a peak at day 15-28 post-infection, the IgG antibody response and plasma neutralizing titers gradually decreased over time but stabilized after 6 months. Compared to G614, plasma neutralizing titers were more than 8-fold lower against variants Beta, Gamma and Delta. SARS-CoV-2-specific memory B and T cells persisted in the majority of patients up to 15 months although a significant decrease in specific T cells, but not B cells, was observed between 6 and 15 months. The antiviral specific immunity especially memory B cells in COVID-19 convalescent patients is long-lasting, but some variants of concern may at least partially escape the neutralizing activity of plasma antibodies.

Category: Biochemistry

Category: Health

Type: Journal article

PubMed 35018336

DOI 10.1016/j.isci.2022.103743

Crossref 10.1016/j.isci.2022.103743

pii: S2589-0042(22)00013-X
pmc: PMC8736281


Publications 7.0.1